Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy

Clinical trial NCT02971683 · COMPLETED

Trial details

NCT number

NCT02971683

Sponsor

Bristol-Myers Squibb

Status

COMPLETED

Phase

Phase 3

Study type

INTERVENTIONAL

Start date

2017-05-04

Primary completion

2020-07-27

Enrollment

149

View on ClinicalTrials.gov